Triamcinolone Injectable (IM, intra-articular) bulk supplier for pharma manufacturers

Triamcinolone Injectable (IM, Intra-Articular) Suppliers & Bulk Manufacturers

Available Forms: Injectable (IM, intra-articular)

Available Strengths: 40 mg/mL, 80 mg/mL, 80 mg/2 mL

Reference Brands: Kenalog(US & EU)

Category: Arthritis

Triamcinolone injectable inhibits inflammation by suppressing cytokine production, decreasing immune activity, and reducing tissue swelling. It provides rapid relief in joint flare-ups, arthritis, and allergic conditions. Benefits include targeted, long-lasting anti-inflammatory effects, improved joint function, and minimized systemic side effects when used appropriately, making it effective for acute and chronic inflammatory management.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Triamcinolone Injectable (IM, Intra-Articular)? List it or send an offer →

Product Description:

Triamcinolone injectable (IM and intra-articular) is approved in the EU and US for managing inflammatory and autoimmune conditions, including rheumatoid arthritis. In the EU, brands like Kenalog are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on comprehensive clinical data and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. We facilitate efficient market access for triamcinolone injectable formulations, ensuring adherence to European and US standards for safe, effective anti-inflammatory therapy and seamless navigation of complex regulatory landscapes.

Triamcinolone Injectable (IM, Intra-Articular) — third party manufacturing & bulk supply

Triamcinolone Injectable (IM, Intra-Articular) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Triamcinolone Injectable (IM, Intra-Articular) is supplied as Injectable (IM, intra-articular) — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Triamcinolone Injectable (IM, Intra-Articular) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Triamcinolone Injectable (IM, Intra-Arti... →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Triamcinolone acetonide is used to treat various inflammatory and allergic conditions, including skin disorders (such as eczema, dermatitis, and psoriasis), allergic rhinitis, arthritis, and certain mouth ulcers. It is a corticosteroid that works by reducing inflammation, redness, swelling, and itching associated with allergic and immune-mediated reactions.

Triamcinolone acetonide is made from the active ingredient triamcinolone acetonide, a synthetic corticosteroid derived from triamcinolone. Its chemical name is 9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone. Inactive ingredients vary depending on the dosage form, such as creams, injections, or nasal sprays.

The trade names of triamcinolone acetonide include Kenalog, Nasacort, Aristocort, and Triderm, depending on the formulation and country.

Triamcinolone acetonide (Kenalog) was originally developed by Bristol-Myers Squibb and is now manufactured by several pharmaceutical companies globally, including Teva, Glenmark, and Sun Pharma, under various brand names.

The generic name of the drug is triamcinolone acetonide.

The brand names include Kenalog, Aristocort, Nasacort, and Triderm.

Triamcinolone acetonide is manufactured in multiple countries, including the United States, the United Kingdom, and India, by companies such as Bristol-Myers Squibb, Teva, and Sun Pharma, depending on the formulation and market.